Supplemental folates in the therapy of Plasmodium falciparum malaria.
D000284:Administration, Oral; D000740:Anemia / Q000139:chemically induced / Q000517:prevention & control; D000962:Antimalarials / Q000008:administration & dosage* / Q000009:adverse effects; D001792:Blood Platelets; D002738:Chloroquine / Q000008:administration & dosage / Q000009:adverse effects; D002986:Clinical Trials as Topic; D005492:Folic Acid / Q000008:administration & dosage*; D006400:Hematocrit; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage*; D007958:Leukocyte Count; D007970:Leukopenia / Q000139:chemically induced / Q000517:prevention & control; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D008887:Military Medicine; D010919:Placebos; D010963:Plasmodium falciparum; D011739:Pyrimethamine / Q000008:administration & dosage / Q000009:adverse effects; D013444:Sulfisoxazole / Q000008:administration & dosage / Q000009:adverse effects; D014744:Vietnam
D000962:Antimalarials; D010919:Placebos; D013444:Sulfisoxazole; D002738:Chloroquine; D005492:Folic Acid; D002955:Leucovorin; D011739:Pyrimethamine